Launch of New Drug Lifted Ascendis Pharma A
In its first-quarter 2025 investor letter, Artisan Mid Cap Fund highlighted stocks such as Ascendis Pharma A/S (NASDAQ:ASND). Ascendis Pharma A/S (NASDAQ:ASND) is a biopharmaceutical company. The one-month return of Ascendis Pharma A/S (NASDAQ:ASND) was 21.84%, and its shares gained 27.42% of their value over the last 52 weeks. On May 5, 2025, Ascendis Pharma A/S (NASDAQ:ASND) stock closed at $170.74 per share with a market capitalization of $10.308 billion.
Artisan Mid Cap Fund stated the following regarding Ascendis Pharma A/S (NASDAQ:ASND) in its Q1 2025 investor letter:
"Among our top Q1 contributors were Spotify, Ascendis Pharma A/S (NASDAQ:ASND) and AutoZone. Shares of Ascendis experienced strength in the quarter due to the launch of its latest drug, Yorvipath. The drug treats hypoparathyroidism—a rare endocrine disorder with limited effective treatments. Our view is that this will be a significant profit cycle driver, given the sizable addressable market and the unmet needs in current care. Yorvipath was approved and launched in December, and the company's latest earnings results showed the launch is running well ahead of expectations. While it's still early, initial prescription data supports our bullish view of sales that could exceed market expectations by a wide margin. Meanwhile, Ascendis has a third promising drug, Transcon CNP (to treat achondroplasia), that was submitted for FDA approval in Q1 and could be launched in 2026."
Is Ascendis Pharma A/S (ASND) the Best Growth Stock to Buy According to Billionaires?
A close-up view of a hand manipulating a syringe while delivering TransCon CNP into a tumor.
Ascendis Pharma A/S (NASDAQ:ASND) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 45 hedge fund portfolios held Ascendis Pharma A/S (NASDAQ:ASND) at the end of the fourth quarter, compared to 43 in the third quarter. While we acknowledge the potential of Ascendis Pharma A/S (NASDAQ:ASND) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 minutes ago
- Yahoo
Roku Beats, But Margin Drift Clouds Rally
Roku (NASDAQ:ROKU) beat again in Q2 $1.11 billion revenue, GAAP EPS $0.07, both ahead of expectations but the stock slipped because the story wasn't all clean. Platform revenue was the strength, up 18% to $975.5 million, helped by video ads and the Frndly deal, while device sales fell 6% to $135.6 million. Warning! GuruFocus has detected 7 Warning Signs with BOM:500400. That mix showed up in the margin math: gross margin slid to 44.8%, with platform gross margins softening to 51.0%, and investors focused on that erosion even as the top line surprised. Roku tried to push back. It lifted its full-year platform revenue target to $4.075 billion, said adjusted EBITDA should improve, and rolled out a $400 million buyback to neutralize equity dilution and signal confidence. The message was basically: growth is real, cash flow is coming, and we're backing the stock. Still, the market saw the margin pressure and the need for share support and took it as a warning shot, trimming the stock before the open. Demand is there, but profitability is wobbling a bit. The next few quarters will show whether Roku can get margins back on track and turn that buyback into real per-share value. This article first appeared on GuruFocus.
CNBC
5 minutes ago
- CNBC
Sell Coinbase as crypto stock's rally runs out of steam, says Compass Point
Coinbase's lackluster second-quarter results could mean the stock's momentum may start to wane, according to Compass Point Research. The firm downgraded Coinbase to sell from neutral in a Sunday note. It also trimmed its price target to $248 per share from $330, signaling more than 21% downside from Friday's $314.69 close. Coinbase has been on fire this year, advancing more than 26%. COIN YTD mountain COIN year to date The rating change comes after Coinbase reported mixed second-quarter results last week. The company's earnings per share beat analyst expectations, but revenue missed. Revenue tied to transactions, a key metric for the company, also came in below a StreetAccount consensus estimate. "COIN's 2Q/3Q trends affirm weakening earnings despite an ongoing crypto bull market," analyst Ed Engel said. "We see limited support for COIN's valuation if crypto markets sell off further." Engel also attributed part of the downgrade to potential weakness in the price of cryptocurrencies from here. "While we remain constructive on the current crypto cycle, we expect a choppy 3Q alongside weak August/September seasonality and waning retail interest in crypto treasury stocks," Engel said. Flagship cryptocurrency bitcoin is up 22% year to date, trading above $114,000. Earlier this year, it reached $120,000 for the first time. The analyst also said he expects higher stablecoin competition to be a headwind. Stablecoins are cryptos that are pegged to fiat currencies, such as the dollar. At the same time, Engle noted that Coinbase's valuation may have little room to expand. Coinbase trades at 44 times forward earnings, while the S & P 500 has a multiple of 23, per FactSet.
Associated Press
5 minutes ago
- Associated Press
Workhorse Reenters Exclusivity Period in Connection with Potential Transaction
CINCINNATI, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Workhorse Group Inc. (Nasdaq: WKHS) ('Workhorse' or the 'Company'), an American technology company focused on pioneering the transition to zero-emission commercial vehicles, today announced it has entered into a new exclusivity agreement with a privately held U.S.-based manufacturer of electric commercial vehicles (the 'Manufacturer') in connection with a previously disclosed potential transaction. As previously announced, the Company is currently in discussions with the Manufacturer about a potential transaction in which the Manufacturer would be merged into a newly created subsidiary of the Company in exchange for newly issued shares of the Company's common stock (the 'Potential Transaction'). In connection with the Potential Transaction, on July 14, 2025, the Company entered into an Exclusivity Agreement (the 'Prior Exclusivity Agreement') with the Manufacturer, which provided that, for a period of 14 days and subject to a customary 'fiduciary out,' the Company would not, among other things, provide information to, negotiate with or enter into a definitive agreement with a third party for an alternative transaction to the Potential Transaction (collectively, the 'Restrictions'). On July 28, 2025, the Restrictions under the Prior Exclusivity Agreement expired. On August 4, 2025, the Company entered into a new Exclusivity Agreement (the 'New Exclusivity Agreement'), which put the Restrictions on the Company from the Prior Exclusivity Agreement back into place for a period of seven days. Additional Information and Where to Find It If definitive agreements are entered into with respect to the Potential Transaction, the Company intends to file a proxy statement with the Securities and Exchange Commission (the 'SEC') and may file other relevant documents with the SEC regarding the Potential Transaction. This communication is not a substitute for the proxy statement or any other document that the Company may file with the SEC. The proxy statement (if and when available) will be mailed to stockholders of the Company. STOCKHOLDERS ARE ADVISED TO READ THE PROXY STATEMENT, AND ANY OTHER RELEVANT DOCUMENTS THAT MAY BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE POTENTIAL TRANSACTION. Stockholders will be able to obtain a free copy of the proxy statement (if and when available) and other relevant documents once such documents are filed with the SEC from the SEC's website at or by directing a request by mail to Workhorse Group Inc., 3600 Park 42 Drive, Suite 160E, Sharonville, Ohio 45241, or from the Company's website at Participants in the Solicitation If definitive agreements are entered into with respect to the Potential Transaction, the Company and certain of its directors and officers may, under the rules of the SEC, be deemed to be 'participants' in the solicitation of proxies from its stockholders that will occur in connection with the meeting at which the Potential Transaction may be presented to stockholders for approval (the 'Meeting'). Information concerning the interests of the persons who may be considered 'participants' in the solicitation is set forth in the Company's proxy statements and its Annual Reports on Form 10-K previously filed with the SEC, and will be set forth in the proxy statement relating to the Meeting when the proxy statement becomes available. Copies of these documents can be obtained, without charge, at the SEC's website at or by directing a request to the Company at the address above, or at Cautionary Note Regarding Forward-Looking Statements This press release contains 'forward-looking statements' within the meaning of Section 21E of the Exchange Act, and the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements may relate to the Company's initial business combination and any other statements relating to future results, strategy and plans of the Company (including statements which may be identified by the use of the words 'plans', 'expects' or 'does not expect', 'estimated', 'is expected', 'budget', 'scheduled', 'estimates', 'forecasts', 'intends', 'anticipates' or 'does not anticipate', 'targets', 'projects', 'contemplates', 'predicts', 'potential', 'continue', or 'believes', or variations of such words and phrases or state that certain actions, events or results 'may', 'could', 'would', 'should', 'might', 'will' or 'will be taken', 'occur' or 'be achieved'). Forward-looking statements are based on the opinions and estimates of management of the Company as of the date such statements are made, and they are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. These risks and uncertainties could give rise to a delay in or the failure to enter into a definitive agreement relating to, or the Company's ability to enter into a definitive agreement or consummate the Potential Transaction. Some factors that could cause actual results to differ include the outcome of discussions between the Company and the Manufacturer with respect to the Potential Transaction, including the possibility that the parties may not agree to pursue the Potential Transaction or that the terms of the Potential Transaction will be materially different from those described herein; our ability to consummate the Potential Transaction or achieve the expected synergies and/or efficiencies; potential regulatory delays; the industry and market reaction to this announcement; the effect of the announcement of the Potential Transaction on the ability of the parties to operate their businesses and retain and hire key personnel and to maintain favorable business relationships; the possibility that the integration of the parties may be more difficult, time-consuming or costly than expected or that operating costs and business disruptions may be greater than expected; the ability to obtain regulatory and other approvals required to consummate the Potential Transaction, including from Nasdaq; the risk that the price of our securities may be volatile due to a variety of factors; changes in laws, regulations, technologies, the global supply chain, and macro-economic and social environments affecting our business; and our ability to maintain compliance with Nasdaq rules and otherwise maintain our listing of securities on Nasdaq. Additional information on these and other factors that may cause actual results and the Company's performance to differ materially is included in the Company's periodic reports filed with the SEC, including, but not limited to, the Company's Annual Report on Form 10-K for the year ended December 31, 2024, including those factors described under the heading ' Risk Factors ' therein, and the Company's subsequent Quarterly Reports on Form 10-Q. Copies of the Company's filings with the SEC are available publicly on the SEC's website at or may be obtained by contacting the Company. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. These forward-looking statements are made only as of the date hereof, and the Company undertakes no obligations to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. No Offer or Solicitation This press release does not constitute a solicitation of a vote or a proxy, consent or authorization with respect to any securities. This press release also does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor will there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities will be made except by means of a prospectus meeting the requirements of the Securities Act, or an exemption therefrom. Media Contact: Aaron Palash / Greg Klassen Joele Frank, Wilkinson Brimmer Katcher 212-355-4449 Investor Relations Contact: Tom Colton and Greg Bradbury Gateway Group 949-574-3860 [email protected]
